{"id":"W2851615044","doi":"10.1136/esmoopen-2018-000364","title":"Patient-reported outcomes in a phase II, North American study of alectinib in patients with ALK-positive, crizotinib-resistant, non-small cell lung cancer","year":2018,"lang":"en","type":"article","venue":"ESMO Open","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital","funders":"National Cancer Institute; F. Hoffmann-La Roche","keywords":"Alectinib; Medicine; Crizotinib; Lung cancer; Tolerability; Internal medicine; Quality of life (healthcare); ALK inhibitor; Performance status; Clinical endpoint; Oncology; Cancer; Adverse effect; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002355894,0.000635151,0.0009498762,0.0002522509,0.0005361223,0.0006719793,0.0003314214,0.0005951512,0.0006808349],"category_scores_gemma":[0.00127523,0.0003190223,0.0006007688,0.0005482976,0.0004030351,0.0003621324,0.000338083,0.0007778918,0.0002421241],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006282542,"about_ca_system_score_gemma":0.0008152867,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001994325,"about_ca_topic_score_gemma":0.003565777,"domain_scores_codex":[0.9991585,0.0004705656,0.00005599438,0.0001280139,0.0001195859,0.00006736977],"domain_scores_gemma":[0.9988098,0.0001841012,0.0004046551,0.00008348854,0.0001559016,0.0003619913],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.09752895,0.009147013,0.8562227,0.0004049798,0.002839973,0.0004527897,0.00064447,0.0009446564,0.007393291,0.00007097386,0.002163703,0.02218654],"study_design_scores_gemma":[0.01584737,0.01216054,0.968141,0.00002610596,0.0007043761,0.0004388662,0.0001377957,0.0007254851,0.000464225,0.00003778721,0.001288635,0.00002762079],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9986525,0.0004707976,0.00005316777,0.00007847427,0.000008886377,0.0001049499,0.0003286478,0.000003550816,0.0002990424],"genre_scores_gemma":[0.9978083,0.0002514554,0.0001738594,0.0002099432,0.00002671471,0.0001968521,0.001075033,0.000002789921,0.0002551849],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002355894,"threshold_uncertainty_score":0.01245928,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01323684407167879,"score_gpt":0.3460740368954021,"score_spread":0.3328371928237233,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}